Nephros (NEPH) Cost of Revenue (2010 - 2026)

Nephros' Cost of Revenue history runs 17 years deep, the most recent figure standing at $2.2 million for Q1 2026.

• In Q1 2026, Cost of Revenue rose 28.79% year-over-year to $2.2 million; the TTM figure through Mar 2026 stood at $7.7 million (up 31.46% YoY), while the FY2025 annual figure was $7.2 million, up 31.72% from the prior year.
• Cost of Revenue was $2.2 million for Q1 2026 at Nephros, up from $2.0 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $2.2 million in Q1 2026 to a low of $1.0 million in Q4 2022.
• Historically, Cost of Revenue has averaged $1.5 million across 5 years, with a median of $1.5 million in 2023.
• The sharpest annual moves came in 2022 and 2024: Cost of Revenue jumped 46.82% in 2022, then fell 15.83% in 2024.
• A 5-year view of Cost of Revenue shows it stood at $1.0 million in 2022, then climbed by 17.54% to $1.2 million in 2023, then grew by 13.14% to $1.4 million in 2024, then soared by 41.08% to $2.0 million in 2025, then grew by 12.75% to $2.2 million in 2026.
• The last three Cost of Revenue figures came in at $2.2 million (Q1 2026), $2.0 million (Q4 2025), and $1.8 million (Q3 2025), per Business Quant data.